M&T Bank Corp Buys 10,350 Shares of Regeneron Pharmaceuticals, Inc. $REGN

robot
Abstract generation in progress

M&T Bank Corp significantly increased its stake in Regeneron Pharmaceuticals Inc. by 193.9%, acquiring an additional 10,350 shares to hold a total of 15,689 shares valued at $12.11 million. This increase follows positive developments for Regeneron, including FDA approval of a gene therapy and favorable analyst upgrades, despite some potential near-term revenue limitations due to providing the therapy for free to eligible U.S. patients. The company also reported strong Q4 EPS, raised its dividend, and maintains a “Moderate Buy” consensus rating among analysts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin